ADMA BIOLOGICS, INC. Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
ADMA BIOLOGICS, INC. (ADMA) had Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals of $4.32 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals · last filed 2026-02-25
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $4.32M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $5.78M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $5.83M; Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals as first filed $1.15M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $1.24M; Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals as first filed $1.24M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals as first filed |
|---|---|---|
| 2025-12-31 | $4.32M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $5.78M 10-K · filed 2026-02-25 | |
| 2023-12-31 | $5.83M 10-K · filed 2025-03-18 | $1.15M 10-K · filed 2024-02-28 |
| 2022-12-31 | $1.24M 10-K · filed 2024-02-28 | $1.24M 10-K · filed 2023-03-23 |
| 2021-12-31 | $1.03M 10-K · filed 2023-03-23 | |
| 2020-12-31 | $2.40M 10-K · filed 2022-03-24 | |
| 2019-12-31 | $2.43M 10-K · filed 2021-03-25 | |
| 2018-12-31 | $6.01M 10-K · filed 2020-03-13 | |
| 2017-12-31 | $951.22K 10-K · filed 2019-03-13 | |
| 2016-12-31 | $747.59K 10-K · filed 2018-03-29 | |
| 2015-12-31 | $350.68K 10-K · filed 2017-02-24 | $1.37M 10-K · filed 2016-03-23 |
| 2014-12-31 | $884.47K 10-K · filed 2016-03-23 | |
| 2013-12-31 | $752.95K 10-K · filed 2015-03-09 | |
| 2012-12-31 | $0.00 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |